Search results

Journal Article (3)

  1. 1.
    Journal Article
    Coscia, F.; Lengyel, E.; Duraiswamy, J.; Ashcroft, B.; Bassani-Sternberg, M.; Wierer, M.; Johnson, A.; Wroblewski, K.; Montag, A.; Yamada, S. D. et al.; Lopez-Mendez, B.; Nilsson, J.; Mund, A.; Mann, M.; Curtis, M.: Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer. Cell 175 (1), pp. 159 - 170.e16 (2018)
  2. 2.
    Journal Article
    Doll, S.; Kriegmair, M. C.; Santos, A.; Wierer, M.; Coscia, F.; Neil, H. M.; Porubsky, S.; Geyer, P. E.; Mund, A.; Nuhn, P. et al.; Mann, M.: Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient. Molecular Oncology 12 (8), pp. 1296 - 1307 (2018)
  3. 3.
    Journal Article
    Coscia, F.; Watters, K. M.; Curtis, M.; Eckert, M. A.; Chiang, C. Y.; Tyanova, S.; Montag, A.; Lastra, R. R.; Lengyel, E.; Mann, M.: Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status. Nature Communications (2016)

Meeting Abstract (4)

  1. 4.
    Meeting Abstract
    Coscia, F.; Lengyel, E.; Duraiswamy, J.; Ashcroft, B.; Bassani-Sternberg, M.; Wierer, M.; Johnson, A.; Wroblewski, K.; Montag, A.; Yamada, S. D. et al.; Mann, M.; Curtis, M.: Proteomics identifies CT45 as a mediator of chemosensitivity and immunotherapy target in ovarian cancer. In: Clinical Cancer Research, Vol. 24, p. 95 - 95. AACR Special Conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment, Pittsburgh, PA, October 01, 2017 - October 04, 2017. Association for Cancer Research, Denville, NJ (2018)
  2. 5.
    Meeting Abstract
    Eckert, M. A.; Coscia, F.; Chryplewicz, A.; Chang, J. W.; Pan, S.; Tienda, S. M.; Lastra, R. R.; Curtis, M.; Yamada, S. D.; McGregor, S. M. et al.; Moellering, R. E.; Mann, M.; Lengyel, E.: Nicotinamide N-methyltransferase metabolically reprograms the stroma to promote ovarian cancer metastasis. In: Clinical Cancer Research, Vol. 24, p. 30 - 30. AACR Special Conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment, Pittsburgh, PA, October 01, 2017 - October 04, 2017. Association for Cancer Research, Denville, NJ (2018)
  3. 6.
    Meeting Abstract
    Eckert, M. A.; Coscia, F.; Chryplewicz, A.; Chang, J. W.; Pan, S.; Tienda, S. M.; Lastra, R. R.; Curtis, M.; Yamada, S. D.; McGregor, S. M. et al.; Moellering, R. E.; Mann, M.; Lengyel, E.: Beta-escin inhibits ovarian cancer metastasis by targeting the tumor microenvironment. In: Clinical Cancer Research, Vol. 24, pp. 52 - 53. AACR Special Conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment, Pittsburgh, PA, October 01, 2017 - October 04, 2017. Association for Cancer Research, Denville, NJ (2018)
  4. 7.
    Meeting Abstract
    Mukherjee, A.; Coscia, F.; Fahrmann, J.; Chiang, C.-Y.; Smith, J.; Nieman, K.; Ladanyi, A.; Romero, I.; Fiehn, O.; Mann, M. et al.; Lengyel, E.: Fatty acid binding protein 4 is indispensable for ovarian cancer metastasis. In: Clinical Cancer Research, Vol. 24, p. 45 - 45. AACR Special Conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment, Pittsburgh, PA, October 01, 2017 - October 04, 2017. Association for Cancer Research, Denville, NJ (2018)

Thesis - PhD (1)

  1. 8.
    Thesis - PhD
    Coscia, F.: Ovarian Cancer Proteomics. Dissertation, Ludwig-Maximilians-Universität, München (2016)
 
loading content
Go to Editor View